Summary of studies reporting ERCC1 expression and outcomes in non-small cell and small-cell lung cancer patients.

<p>RTqPCR, reverse transcriptase quantitative polymerase chain reaction; IHC, immunohistochemistry; MIC, mitomycin/ifosfamide/cisplatin; MVP, mitomycin/vinblastine/cisplatin; chemoRT, chemoradiotherapy; NS, not stated;</p><p>*, number of patients assessable for ERCC1 expression and overall survival;</p>ƒ<p>, one patient received adjuvant chemoradiotherapy;</p>⌋<p>, % high ERCC1 expression overall (data not stated for subgroups separately).